Filing Details
- Accession Number:
- 0001225208-16-033173
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-05-11 18:04:56
- Reporting Period:
- 2016-05-10
- Filing Date:
- 2016-05-11
- Accepted Time:
- 2016-05-11 18:04:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
78003 | Pfizer Inc | PFE | Pharmaceutical Preparations (2834) | 135315170 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1551792 | D John Young | Pfizer Inc.-Corp. Secretary 235 East 42Nd St. New York NY 10017 | Group President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-05-10 | 41,700 | $25.87 | 200,399 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-05-10 | 400 | $33.54 | 199,999 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-05-10 | 500 | $33.57 | 199,499 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-05-10 | 700 | $33.55 | 198,799 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-05-10 | 782 | $33.50 | 198,017 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-05-10 | 1,400 | $33.56 | 196,617 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-05-10 | 1,475 | $33.49 | 195,142 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-05-10 | 4,525 | $33.58 | 190,617 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-05-10 | 14,800 | $33.52 | 175,817 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-05-10 | 17,118 | $33.53 | 158,699 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2016-05-10 | 41,700 | $0.00 | 41,700 | $25.87 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2017-02-21 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,306 | Indirect | By Rule 16b-3 Plan |
Common Stock | 1,348 | Indirect | By Trustee under the Pfizer Share Ownership Plan |
Footnotes
- These options are fully exercisable.